Regulatory status · Brazil
Swiss Vitalis LLC · Newark, DE · USA ·Swiss Vitalis LLC is a Delaware company that owns the Swiss Vitalis brand of hemp-derived CBD products. The products are made in the United States by a contract manufacturer and sold in the United States by Novus Byzantium LLC, a Wyoming company. Neither company is registered with ANVISA and neither sells, ships, offers, advertises or solicits in Brazil.
Swiss Vitalis CBD appears in Annex I of ANVISA’s published reference of cannabis-derived products eligible for the individual personal-import procedure under RDC 660/2022, Art. 5º §3º. Current edition: Nota Técnica nº 81/2026/SEI/COCIC/GPCON/DIRE5/ANVISA, signed 2 October 2026, process 25351.927642/2021-31.
ANVISA expressly states in the same Nota Técnica that products listed in this reference are not registered with ANVISA and have not had their efficacy, quality or safety evaluated by the Agency. Inclusion in the reference does not constitute registration, approval, endorsement, recommendation, or commercial authorization. ANVISA further states that these products may not be imported, stored, distributed, or resold by legal entities in Brazil, a restriction that arises from Lei nº 6.360/1976, and must be imported exclusively by the natural-person patient for strictly personal, non-transferable use, with delivery to third parties prohibited, under Arts. 15 and 20 of RDC 660/2022.
Swiss Vitalis makes no claim about what any product does. These statements have not been evaluated by the Food and Drug Administration, and the products are not intended to diagnose, treat, cure, or prevent any disease.
ANVISA may suspend or revoke an individual import authorization at any time (RDC 660/2022, Art. 14). Nothing on this page is an offer to sell, an invitation to purchase, or medical, regulatory or legal advice, and nothing here promises an outcome for any application.